During the past decade, Arena Oncology Associates, PC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arena Oncology Associates, PC" #1 sponsor was "Celgene" with 6 trials, followed by "Morphotek" with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored and "Accelerated Community Oncology Research Network" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arena Oncology Associates, PC" #1 collaborator was "Bionomics Limited" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Arena Oncology Associates, PC" are "Breast Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Pancreatic Cancer" (3 trials), "Metastatic Pancreatic Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Arena Oncology Associates, PC" in a lesser frequency.

Most popular intervention types in "Arena Oncology Associates, PC" are "Drug" (21 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (7 trials), "Placebo" (4 trials), "ASA404" (2 trials), "Capecitabine" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arena Oncology Associates, PC" are 17 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Arena Oncology Associates, PC". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Arena Oncology Associates, PC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Arena Oncology Associates, PC, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".